Completed NA INTERVENTIONAL 2-arm NCT03561519

FMT in the Treatment of IBS (FMT-IBS)

FECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME

Sponsor: Helsinki University Central Hospital

Interventions Fecal Microbiota Transplantation (FMT) Placebo

Updated 6 times since 2018 Last updated: Aug 14, 2018 Started: Aug 27, 2015 Primary completion: Jul 1, 2018 Completion: Jul 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Irritable Bowel Syndrome and is currently completed. Helsinki University Central Hospital leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA
Sep 2018 — Apr 2020 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jul 2018 — Sep 2018 [monthly]

Active Not Recruiting NA

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helsinki University Central Hospital
Joint Authority for Päijät-Häme Social and Health Care
University of Helsinki

Data source: Joint Authority for Päijät-Häme Social and Health Care

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Helsinki, Finland